300573 Stock Overview
Engages in the research and development, production, and sale of ophthalmic medications in the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 6/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Shenyang Xingqi Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥200.11 |
| 52 Week High | CN¥214.28 |
| 52 Week Low | CN¥80.17 |
| Beta | 0.032 |
| 1 Month Change | 31.84% |
| 3 Month Change | 87.96% |
| 1 Year Change | 101.96% |
| 3 Year Change | 159.02% |
| 5 Year Change | n/a |
| Change since IPO | 184.62% |
Recent News & Updates
Recent updates
Shareholder Returns
| 300573 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -4.1% | -1.6% | 1.1% |
| 1Y | 102.0% | -10.9% | -10.2% |
Return vs Industry: 300573 exceeded the CN Pharmaceuticals industry which returned -10.9% over the past year.
Return vs Market: 300573 exceeded the CN Market which returned -10.2% over the past year.
Price Volatility
| 300573 volatility | |
|---|---|
| 300573 Average Weekly Movement | 7.1% |
| Pharmaceuticals Industry Average Movement | 5.8% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in CN Market | 10.7% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 300573's share price has been volatile over the past 3 months.
Volatility Over Time: 300573's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1977 | 1,995 | E. Gao | www.sinqi.com |
Shenyang Xingqi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of ophthalmic medications in the People’s Republic of China. The company offers corneal, anti-bacteria, artificial tears, anti-inflammation, anti-allergic, mydriactics, anti-fatigue, and dry eye treatment products.
Shenyang Xingqi Pharmaceutical Co.,Ltd. Fundamentals Summary
| 300573 fundamental statistics | |
|---|---|
| Market cap | CN¥34.90b |
| Earnings (TTM) | CN¥255.44m |
| Revenue (TTM) | CN¥1.53b |
136.6x
P/E Ratio22.8x
P/S RatioIs 300573 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300573 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.53b |
| Cost of Revenue | CN¥355.10m |
| Gross Profit | CN¥1.18b |
| Other Expenses | CN¥920.35m |
| Earnings | CN¥255.44m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.46 |
| Gross Margin | 76.80% |
| Net Profit Margin | 16.69% |
| Debt/Equity Ratio | 5.8% |
How did 300573 perform over the long term?
See historical performance and comparisonDividends
3.0%
Current Dividend Yield196%
Payout RatioDoes 300573 pay a reliable dividends?
See 300573 dividend history and benchmarks| Shenyang Xingqi PharmaceuticalLtd dividend dates | |
|---|---|
| Ex Dividend Date | May 22 2024 |
| Dividend Pay Date | May 22 2024 |
| Days until Ex dividend | 0 days |
| Days until Dividend pay date | 0 days |
Does 300573 pay a reliable dividends?
See 300573 dividend history and benchmarks